Bill > HB06062

This bill aims to prohibit direct-to-consumer prescription drug advertisements within the state, specifically targeting any advertisements for legend drugs (prescription medications) directed at consumers physically present in the state. The bill defines key terms such as "consumer," "legend drug," "pharmaceutical manufacturer," and "pharmaceutical representative" by referencing existing state statutes. Pharmaceutical manufacturers registered with the Department of Consumer Protection are still allowed to promote or provide information about legend drugs to prescribing practitioners (medical professionals who can write prescriptions). The Commissioner of Consumer Protection is authorized to develop regulations to implement the bill's provisions, and any violation of the advertising prohibition will be considered an unfair or deceptive trade practice under state law. The bill is set to take effect on October 1, 2025, and is designed to restrict pharmaceutical marketing directly to consumers while maintaining professional communication channels between drug manufacturers and healthcare providers.

Budget and Finance, Justice

General Law Committee (J)

https://www.cga.ct.gov/asp/cgabillstatus/cgabillstatus.asp?selBillType=Bill&bill_num=HB06062&which_year=2025